Skip to main content

Screening for Skin Cancer

  • Chapter
Cancer Screening

Part of the book series: Current Clinical Practice ((CCP))

  • 116 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anon. (1999) 1999 Skin cancer fact sheet. Cutis 64: 52D.

    Google Scholar 

  2. Stern RS. (1999) The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 135: 843, 844.

    Google Scholar 

  3. Serraino D, Fratino L, Gianni W, et al. (1998) Epidemiological aspects of cutaneous malignant melanoma. Oncol Rep 5: 905–909.

    PubMed  CAS  Google Scholar 

  4. Landis SH, Murray T, Bolden S, et al. (1999) Cancer statistics, 1999. CA Cancer J Clin 49: 8–31.

    Article  PubMed  CAS  Google Scholar 

  5. Weinstock MA. (1997) Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol 133: 1207–1209.

    Article  PubMed  CAS  Google Scholar 

  6. Armstrong BK, Kriker A. (1995) Skin cancer. Dermatol Clin 13: 583–594.

    PubMed  CAS  Google Scholar 

  7. Hall HI, Miller DR, Rogers JD, et al. (1999) Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40: 35–42.

    Article  PubMed  CAS  Google Scholar 

  8. Gloecklier-Ries LA, Kosary CL, Hankey BF, et al. (1997) SEER Cancer Statistics Review, 1973–1994. Bethesda, MD: National Cancer Institute, pp. 305–318.

    Google Scholar 

  9. Dennis LK. (1999) Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135: 275–280.

    Article  PubMed  CAS  Google Scholar 

  10. MacKie RM, Hole D, Hunter JA, et al. (1997) Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979–94. The Scottish Melanoma Group. Br Med J 315: 1117–1121.

    Article  CAS  Google Scholar 

  11. van der Rhee HJ, van der Spek-Keijser LMT, van Westering R, et al. (1999) Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980–95. Br J Dermatol 140: 463–467.

    Article  PubMed  Google Scholar 

  12. Robinson JK. (1997) Clinical crossroads: a 28-year-old fair skinned woman with multiple nevi. JAMA 278: 1693–1699.

    Article  PubMed  CAS  Google Scholar 

  13. Robinson JK, Rigel DS, Amonette RA. (1998) What promotes skin self-examination? JAm Acad Dermatol 38: 752–757.

    Article  PubMed  CAS  Google Scholar 

  14. Czarnecki D. (1998) The prognosis of patients with basal and squamous cell carcinoma of the skin. Int J Dermatol 37: 656–658.

    Article  PubMed  CAS  Google Scholar 

  15. Johnson TM, Hamilton T, Lowe L. (1998) Multiple primary melanomas. JAm Acad Dermatol 39: 422–427.

    Article  CAS  Google Scholar 

  16. Richert SM, D’Amico F, Rhodes AR. (1998) Cutaneous melanoma: patient surveillance and tumor progression. JAm Acad Dermatol 39: 571–577.

    Article  CAS  Google Scholar 

  17. Grossman D, Leffell DJ. (1997) The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 133: 1263–1270.

    Article  PubMed  CAS  Google Scholar 

  18. Gilchrist BA, Eller MS, Geller AC, et al. (1999) The pathogenesis of melanoma induced by ultraviolet radiation N Engl J Med 340: 1341–1348.

    Article  Google Scholar 

  19. Richert SM, D’Amico F, Rhodes AR. (1998) Cutaneous melanoma: patient surveillance and tumor progression. JAm Acad Dermatol 39: 571–577.

    Article  CAS  Google Scholar 

  20. Koh HK, Norton LA, Geller, AC, et al. (1996) Evaluation of the American Academy of Dermatology’s National Skin Cancer Early Detection and Screening Program. JAm Acad Dermatol 34: 971–978.

    Article  PubMed  CAS  Google Scholar 

  21. Weinstock MA. (1998) Mass population skin cancer screening can be worthwhile (if it’s done right). J Cutan Med Surg 2: 129–132.

    PubMed  CAS  Google Scholar 

  22. MacKie RM, Hole D. (1992) Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 304: 1012–1015.

    Article  CAS  Google Scholar 

  23. Cristofolini M, Bianchi R, Boi S, et al. (1993) Effectiveness of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. J Dermatol Surg Oncol 19: 117–120.

    PubMed  CAS  Google Scholar 

  24. Berwick M, Begg CB, Fine JA, et al. (1996) Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 88: 17–23.

    Article  PubMed  CAS  Google Scholar 

  25. Reed JA, Albino AP. (1999) Update of diagnostic and prognostic markers in cutaneous melanoma. Dermatol Clin 17: 631–643.

    Article  PubMed  CAS  Google Scholar 

  26. Rigel DS, Friedman RJ, Kopf AW, et al. (1986) Importance of complete cutaneous examination for the detection of malignant melanoma. JAmAcad Dermatol 14: 857–860.

    Article  PubMed  CAS  Google Scholar 

  27. Czarnecki D, O’Brien T, Meehan C. (1994) Nonmelanoma skin cancer: numbers of cancers and their distribution in outpatients. Int J Dermatol 33: 416, 417.

    Google Scholar 

  28. Rigel DS. (1998) Is the ounce of screening and prevention for skin cancer worth the pound of cure? CA Cancer J Clin 48: 236–238.

    Article  PubMed  CAS  Google Scholar 

  29. Whited JD, Grichnik JM. (1998) Does this patient have a mole or a melanoma? JAMA 279: 696–701.

    Article  PubMed  CAS  Google Scholar 

  30. Grant-Kels JM, Bason ET, Grin CM. (1999) The misdiagnosis of malignant melanoma. JAm Acad Dermatol 40: 539–548.

    Article  PubMed  CAS  Google Scholar 

  31. Engelberg D, Gallagher RP, Rivers JK. (1999) Follow-up and evaluation of skin cancer screening in British Columbia. J Am Acad Dermatol 41: 37–42.

    Article  PubMed  CAS  Google Scholar 

  32. Bolognia JL, Berwick M, Fine JA. (1990) Complete follow-up and evaluation of a skin cancer screening in Connecticut. JAm Acad Dermatol 23: 1098–1106.

    Article  PubMed  CAS  Google Scholar 

  33. Rampen FH, Casparie van Velsen JI, van Huytse BE, et al. (1995) False-negative findings in skin cancer and melanoma screening. JAm Acad Dermatol 33: 59–63.

    Article  PubMed  CAS  Google Scholar 

  34. Grin CM, Kopf AW, Welkovich B, et al. (1990) Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol 126: 763–766.

    Article  PubMed  CAS  Google Scholar 

  35. Witheiler DD, Cockerell CJ. (1991) Histologic features and sensitivity of diagnosis of clinically unsuspected cutaneous melanoma. Am J Dermatopathol 13: 551–556.

    Article  PubMed  CAS  Google Scholar 

  36. Reek MC, Chuang T-Y, Eads TJ, et al. (1999) The diagnostic yield in submitting nevi for histologic examination. JAm Acad Dermatol 40: 567–571.

    Article  Google Scholar 

  37. Wolf IH, Smolle J, Soyer HP, et al. (1998) Sensitivity in the clinical diagnosis of malignant melanoma. Melanoma Res 8: 425–459.

    Article  PubMed  CAS  Google Scholar 

  38. Healsmith MF, Bourke JF, Osborne JE, et al. (1994) An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous melanoma. BrJDermatol 130: 48–50.

    Article  PubMed  CAS  Google Scholar 

  39. McGovern TW, Litaker MS. (1992) Clinical predictors of malignant pigmented lesions: a comparison of the Glasgow seven-point checklist and the American Cancer Society’s ABCDs of pigmented lesions. J Dermatol Surg Oncol 18: 22–26.

    PubMed  CAS  Google Scholar 

  40. Shaw HM, McCarthy WH. (1992) Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. JAm Acad Dermatol 27: 679–682.

    Article  PubMed  CAS  Google Scholar 

  41. Binder M, Schwarz M, Winkler A, et al. (1995) Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 131: 286–291.

    Article  PubMed  CAS  Google Scholar 

  42. Landau M, Matz H, Tur E, et al. (1999) Computerized system to enhance the clinical diagnosis of pigmented cutaneous malignancies. Int J Dermatol 38: 443–446.

    Article  PubMed  CAS  Google Scholar 

  43. Rhodes AR. (1998) Intervention strategy to prevent lethal cutaneous melanoma: use of dermatologie photography to aid surveillance of high-risk persons. J Am Acad Dermatol 39: 262–267.

    Article  PubMed  CAS  Google Scholar 

  44. Gruis NA, van der Velden PA, Bergman W, et al. (1999) Familial melanoma; CDKN2A and beyond. J Invest Dermatol Symp Proc 4: 50–54.

    Article  CAS  Google Scholar 

  45. Monzon J, Liu L, Brill H, et al. (1998) CDKN2A mutations in multiple primary melanomas. N Engl J Med 338: 879–887.

    Article  PubMed  CAS  Google Scholar 

  46. Burden AD, Newell J, Andrew N, et al. (1999) Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 135: 261–265.

    Article  PubMed  CAS  Google Scholar 

  47. Freedberg KA, Geller AC, Miller DR, et al. (1999) Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 41: 738–745.

    Article  PubMed  CAS  Google Scholar 

  48. Tsao H, Rogers GS, Sober AJ. (1998) An estimate of the annual direct cost of treating cutaneous melanoma. JAm Acad Dermatol 38: 669–680.

    Article  PubMed  CAS  Google Scholar 

  49. Cristofolini M, Bianchi R, Boi S, et al. (1993) Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer 71:370–374.

    Article  PubMed  CAS  Google Scholar 

  50. Federman DG, Concato J, Caralis PV, et al. (1997) Screening for skin cancer in primary care settings. Arch Dermatol 133: 1423–1425.

    Article  PubMed  CAS  Google Scholar 

  51. Kirsner RS, Muhkerjee S, Federman DG. (1999) Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol 41: 564–566.

    PubMed  CAS  Google Scholar 

  52. Gerbert B, Maurer T, Berger T, et al. (1996) Primary care physicians as gatekeepers in managed care: primary care physicians’ and dermatologists’ skills at secondary prevention of skin cancer. Arch Dermatol 132: 1030–1038.

    Article  PubMed  CAS  Google Scholar 

  53. Gerbert B, Bronstone A, Wolff M, et al. (1998) Improving primary care residents’ proficiency in the diagnosis of skin cancer. J Gen Intern Med 13: 91–97.

    Article  PubMed  CAS  Google Scholar 

  54. Fader DJ, Wise, CG, Normolle DP, et al. (1998) The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. JAm Acad Dermatol 38: 742–751.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rothe, M.J., Bialy, T.L., Grant-Kels, J.M. (2002). Screening for Skin Cancer. In: Aziz, K., Wu, G.Y. (eds) Cancer Screening. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-191-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-191-6_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-229-2

  • Online ISBN: 978-1-59259-191-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics